CIBC Asset Management’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227K | Sell |
49,107
-1,690
| -3% | -$8.38K | ﹤0.01% | 1238 |
|
|
2026
Q1 | $235K | Sell |
50,797
-1,286
| -2% | -$6.71K | ﹤0.01% | 1136 |
|
|
2025
Q4 | $260K | Buy |
52,083
+1,643
| +3% | +$8.55K | ﹤0.01% | 1057 |
|
|
2025
Q3 | $256K | Sell |
50,440
-7,769
| -13% | -$34.2K | ﹤0.01% | 1013 |
|
|
2025
Q2 | $251K | Hold |
58,209
| – | – | ﹤0.01% | 978 |
|
|
2025
Q1 | $351K | Sell |
58,209
-1,856
| -3% | -$9.38K | ﹤0.01% | 815 |
|
|
2024
Q4 | $237K | Buy |
60,065
+3,266
| +6% | +$14.6K | ﹤0.01% | 1013 |
|
|
2024
Q3 | $332K | Sell |
56,799
-2,128
| -4% | -$10.5K | ﹤0.01% | 841 |
|
|
2024
Q2 | $254K | Sell |
58,927
-3,118
| -5% | -$14.9K | ﹤0.01% | 892 |
|
|
2024
Q1 | $292K | Buy |
62,045
+45,529
| +276% | +$174K | ﹤0.01% | 842 |
|
|
2023
Q4 | $81.1K | Hold |
16,516
| – | – | ﹤0.01% | 1066 |
|
|
2023
Q3 | $90K | Hold |
16,516
| – | – | ﹤0.01% | 1001 |
|
|
2023
Q2 | $153K | Hold |
16,516
| – | – | ﹤0.01% | 999 |
|
|
2023
Q1 | $136K | Buy |
16,516
+707
| +4% | +$7.81K | ﹤0.01% | 974 |
|
|
2022
Q4 | $176K | Sell |
15,809
-6,363
| -29% | -$74K | ﹤0.01% | 955 |
|
|
2022
Q3 | $263K | Hold |
22,172
| – | – | ﹤0.01% | 946 |
|
|
2022
Q2 | $339K | Sell |
22,172
-1,622
| -7% | -$29.2K | ﹤0.01% | 836 |
|
|
2022
Q1 | $503K | Hold |
23,794
| – | – | ﹤0.01% | 837 |
|
|
2021
Q4 | $562K | Buy |
23,794
+1,268
| +6% | +$27.2K | ﹤0.01% | 807 |
|
|
2021
Q3 | $452K | Buy |
22,526
+3,165
| +16% | +$64.9K | ﹤0.01% | 853 |
|
|
2021
Q2 | $389K | Hold |
19,361
| – | – | ﹤0.01% | 884 |
|
|
2021
Q1 | $412K | Buy |
19,361
+2,517
| +15% | +$54.1K | ﹤0.01% | 845 |
|
|
2020
Q4 | $367K | Hold |
16,844
| – | – | ﹤0.01% | 823 |
|
|
2020
Q3 | $297K | Buy |
16,844
+416
| +3% | +$7.74K | ﹤0.01% | 837 |
|
|
2020
Q2 | $309K | Hold |
16,428
| – | – | ﹤0.01% | 789 |
|
|
2020
Q1 | $284K | Hold |
16,428
| – | – | ﹤0.01% | 747 |
|
|
2019
Q4 | $347K | Buy |
16,428
+2,417
| +17% | +$48.9K | ﹤0.01% | 822 |
|
|
2019
Q3 | $274K | Hold |
14,011
| – | – | ﹤0.01% | 872 |
|
|
2019
Q2 | $244K | Hold |
14,011
| – | – | ﹤0.01% | 948 |
|
|
2019
Q1 | $259K | Hold |
14,011
| – | – | ﹤0.01% | 902 |
|
|
2018
Q4 | $225K | Hold |
14,011
| – | – | ﹤0.01% | 888 |
|
|
2018
Q3 | $209K | Hold |
14,011
| – | – | ﹤0.01% | 1042 |
|
|
2018
Q2 | $197K | Buy |
14,011
+1,232
| +10% | +$16.3K | ﹤0.01% | 1059 |
|
|
2018
Q1 | $166K | Hold |
12,779
| – | – | ﹤0.01% | 1002 |
|
|
2017
Q4 | $176K | Hold |
12,779
| – | – | ﹤0.01% | 1014 |
|
|
2017
Q3 | $168K | Buy |
+12,779
| New | +$165K | ﹤0.01% | 988 |
|
|
2016
Q2 | – | Sell |
-18,930
| Closed | -$246K | – | 964 |
|
|
2016
Q1 | $246K | Buy |
18,930
+1,097
| +6% | +$12.5K | ﹤0.01% | 803 |
|
|
2015
Q4 | $205K | Buy |
+17,833
| New | +$204K | ﹤0.01% | 851 |
|
Other funds holding MPT
WAM
TW
COPPSERS
SOADOR
CIBC Asset Management's MPT Position: Q2 2026 in Review
CIBC Asset Management reduced its Medical Properties Trust (MPT) stake by 3.3% in Q2 2026, selling an estimated $8.38K and leaving 49,107 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1238.
CIBC Asset Management first reported a position in MPT in Q4 2015 and has held it in 38 quarters since. The position peaked at $562K in Q4 2021. 158 funds tracked by Wall St. Rank hold MPT as of Q2 2026.
- CIBC Asset Management held 49,107 shares of Medical Properties Trust worth $227K as of Q2 2026.
- CIBC Asset Management sold 1,690 Medical Properties Trust shares in Q2 2026, an estimated $8.38K.
- Medical Properties Trust made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1238 holding.
- CIBC Asset Management first reported a position in Medical Properties Trust in Q4 2015 and has held it in 38 quarters since.
- CIBC Asset Management's Medical Properties Trust position peaked at $562K in Q4 2021.
- 158 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.